Hualan Biological Engineering Inc. (SHE:002007)
China · Delayed Price · Currency is CNY 14.54
+0.12 (0.83%)
May 8, 2026, 3:04 PM CST
SHE:002007 Market Cap
SHE:002007 has a market cap or net worth of 26.57 billion as of May 8, 2026. Its market cap has decreased by -13.36% in one year.
Market Cap
26.57B
Enterprise Value
24.73B
Revenue
4.49B
Ranking
n/a
PE Ratio
30.96
Stock Price
14.54
Market Cap Chart
Since March 3, 2005, SHE:002007's market cap has increased from 1.18B to 26.57B, an increase of 2,149.50%. That is a compound annual growth rate of 15.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 26.57B | -3.90% |
| Dec 31, 2025 | 27.65B | -10.27% |
| Dec 31, 2024 | 30.81B | -23.86% |
| Dec 29, 2023 | 40.47B | -1.97% |
| Dec 30, 2022 | 41.29B | -22.34% |
| Dec 31, 2021 | 53.16B | -31.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Allist Pharmaceuticals | 42.51B |
| Hebei Changshan Biochemical Pharmaceutical | 42.36B |
| Shanghai RAAS Blood Products | 37.24B |
| Chongqing Zhifei Biological Products | 37.03B |
| Beijing Tiantan Biological Products | 28.38B |
| BrightGene Bio-Medical Technology | 28.16B |
| Suzhou Zelgen Biopharmaceuticals | 26.85B |
| Xiamen Amoytop Biotech | 23.33B |